Treatment Options for Insomnia
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for all adult patients with chronic insomnia disorder due to its proven efficacy, long-term benefits, and lack of side effects. 1
First-Line Treatment: Psychological and Behavioral Interventions
Cognitive Behavioral Therapy for Insomnia (CBT-I)
- CBT-I is a multicomponent therapy that includes cognitive therapy, stimulus control, sleep restriction, with or without relaxation therapy 1
- CBT-I has strong evidence supporting its effectiveness for both primary and secondary (comorbid) insomnia 1
- CBT-I can be delivered through various modalities including in-person individual or group therapy, telephone or web-based modules, and self-help books 1
- CBT-I produces results equivalent to sleep medication but with no side effects, fewer relapses, and continued improvement after treatment ends 2
Other Effective Behavioral Interventions
- Stimulus control therapy (establishing a clear association between bed and sleep) is effective as a standalone treatment 1, 3
- Sleep restriction therapy (limiting time in bed to increase sleep efficiency) is recommended for chronic insomnia 1
- Relaxation techniques (progressive muscle relaxation, deep breathing) are effective individual therapies 1, 3
- Multicomponent behavioral therapy without cognitive components is also effective 1
- Biofeedback therapy and paradoxical intention can be used as alternative approaches 1, 3
Sleep Hygiene Considerations
- Sleep hygiene alone is insufficient for treating chronic insomnia but should be used in combination with other therapies 1, 4
- Sleep diary data should be collected before and during treatment to track progress 1
- Clinical reassessment should occur every few weeks until insomnia stabilizes, then every 6 months due to high relapse rates 1
Second-Line Treatment: Pharmacological Options
When CBT-I alone is unsuccessful, pharmacological therapy may be considered using a shared decision-making approach that discusses benefits, harms, and costs 1:
Recommended Medication Sequence
Short to intermediate-acting benzodiazepine receptor agonists or ramelteon:
If initial agent unsuccessful, try alternative short-intermediate acting BzRAs or ramelteon 1
Sedating antidepressants (especially when comorbid depression/anxiety exists):
- Options include trazodone, amitriptyline, doxepin, and mirtazapine 1
Combined BzRA or ramelteon with sedating antidepressant 1
Other sedating agents such as anti-epilepsy medications (gabapentin, tiagabine) or atypical antipsychotics (quetiapine, olanzapine) - these should be reserved for patients with comorbidities who may benefit from the primary action of these drugs 1
Important Medication Considerations
- Short-term hypnotic treatment should be supplemented with behavioral and cognitive therapies 1, 8
- Over-the-counter antihistamines and herbal/nutritional supplements (valerian, melatonin) are not recommended due to lack of efficacy and safety data 1
- Older drugs like barbiturates and chloral hydrate are not recommended 1
- Medication selection should consider symptom pattern, treatment goals, past responses, patient preference, cost, comorbidities, contraindications, and potential drug interactions 1
Treatment Monitoring and Follow-up
- Evaluate treatment efficacy using measures of wake time after sleep onset (WASO), sleep onset latency (SOL), number of awakenings, sleep efficiency, and improvement of sleep-related psychological distress 1
- If a single treatment is ineffective, consider other behavioral therapies, pharmacological options, combined approaches, or reevaluation for occult comorbid disorders 1
- Regular follow-up is essential - every few weeks initially, then monthly until insomnia resolves, followed by biannual check-ins 1
Special Considerations
- Psychological and behavioral treatments are effective for adults of all ages, including older adults and chronic hypnotic users 1, 3
- Older adults more commonly report problems with maintaining sleep rather than falling asleep 1
- Pharmacological treatment carries higher risks in older adults, making behavioral approaches particularly important in this population 1, 5
- Despite its effectiveness, CBT-I remains underutilized due to limited availability of trained practitioners and greater awareness of medication options 2